Bellevue Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6K | Hold |
200
| – | – | 0.01% | 248 |
|
|
2025
Q1 | $16.2K | Hold |
200
| – | – | 0.01% | 242 |
|
|
2024
Q4 | $18K | Hold |
200
| – | – | 0.01% | 241 |
|
|
2024
Q3 | $19.8K | Hold |
200
| – | – | 0.01% | 228 |
|
|
2024
Q2 | $18.5K | Hold |
200
| – | – | 0.01% | 230 |
|
|
2024
Q1 | $19K | Hold |
200
| – | – | 0.01% | 225 |
|
|
2023
Q4 | $17.9K | Hold |
200
| – | – | 0.02% | 232 |
|
|
2023
Q3 | $14.6K | Hold |
200
| – | – | 0.01% | 237 |
|
|
2023
Q2 | $16.6K | Hold |
200
| – | – | 0.01% | 233 |
|
|
2023
Q1 | $15.2K | Hold |
200
| – | – | 0.01% | 244 |
|
|
2022
Q4 | $16.3K | Hold |
200
| – | – | 0.01% | 244 |
|
|
2022
Q3 | $16K | Hold |
200
| – | – | 0.01% | 253 |
|
|
2022
Q2 | $15K | Hold |
200
| – | – | 0.01% | 267 |
|
|
2022
Q1 | $18K | Sell |
200
-150
| -43% | -$13.5K | 0.01% | 268 |
|
|
2021
Q4 | $39K | Hold |
350
| – | – | 0.02% | 204 |
|
|
2021
Q3 | $44K | Sell |
350
-53
| -13% | -$6.66K | 0.03% | 189 |
|
|
2021
Q2 | $55K | Sell |
403
-200
| -33% | -$27.3K | 0.03% | 169 |
|
|
2021
Q1 | $82K | Hold |
603
| – | – | 0.05% | 138 |
|
|
2020
Q4 | $94K | Hold |
603
| – | – | 0.06% | 118 |
|
|
2020
Q3 | $67K | Hold |
603
| – | – | 0.05% | 134 |
|
|
2020
Q2 | $68K | Hold |
603
| – | – | 0.07% | 132 |
|
|
2020
Q1 | $60K | Hold |
603
| – | – | 0.06% | 148 |
|
|
2019
Q4 | $57K | Buy |
+603
| New | +$57K | 0.04% | 138 |
|